Articles

Articles

Article 7: Can PROTACs Truly Become Oral Drugs?

July 22, 2026

Illustration of the three pillars of oral bioavailability, solubility, dissolution rate and permeability, showing how NanoGlass™ formulations support exposure for poorly soluble APIs.

Articles

Article 6: The 3 Pillars of Bioavailability.

May 13, 2026

Scientist handling test tubes with blue liquid in a laboratory during pharmaceutical formulation work

Articles

Article 5: A Formulation Perspective On Protein Degraders

February 9, 2026

Scientist using pipette for GLP toxicology formulation development in SeraNovo laboratory

Articles

Frequently Asked Questions (FAQ)

September 24, 2025

Blue and white capsules representing advanced oral drug formulations in development.

Articles

Article 4: Impact of Formulations in Drug Development

January 7, 2025

Spilled bottle of softgel capsules illustrating oral peptide drug delivery challenges and solutions

Articles

Article 3: Overcoming the Hurdles of Oral Peptide Delivery

February 21, 2024

Scattered softgel capsules illustrating formulation strategies for targeted protein degraders

Articles

Article 2: Overcoming Formulation Challenges in Targeted Protein Degraders

November 22, 2023

Scientist analyzing blue liquid in beakers during drug formulation development research at SeraNovo

Articles

Article 1: Solving Poor Solubility

September 1, 2023